The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.60
Bid: 38.20
Ask: 38.95
Change: -0.65 (-1.66%)
Spread: 0.75 (1.963%)
Open: 39.00
High: 39.00
Low: 38.40
Prev. Close: 39.25
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Futura Medical rises on financing transaction

Thu, 04th Mar 2021 11:42

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Futura Medical, up 22% at 20.08 pence, 12-month range 7.16p-24.49p. The pharmaceutical company says it has entered into financing transactions with HT Riverwood Multi-Growth Fund which will provide the company with up to GBP2 million in cash, GBP1.5 million of which has been received.

----------

Franchise Brands, up 7.7% at 109.30p, 12-month range 81p-136.65p. Says it saw a resilient performance through lockdowns and a robust recovery in second half. For 2020, revenue increases by 12% to GBP49.3 million from GBP44.0 million in 2019 and pretax profit increases to GBP3.7 million from GBP3.3 million. Franchise Brands ups final dividend to 0.80p per share from 0.65p paid in 2019.

----------

ThinkSmart, up 6.7% at 77.9p, 12-month range 12p-91.5p. The digital payments business posts rise in interim earnings. For six months to December 31, pretax profit surges to GBP53.7 million from GBP16.0 million after financial instruments gains. ThinkSmart pays 3.4p per share special dividend and capital return in December.

----------

AIM - LOSERS

----------

MediaZest, down 16% at 0.080p, 12-month range 0.01p-0.18p. The audio-visual company says financial results for the eighteen-month period were affected substantially by the Covid-19 pandemic, with reduction in revenue particularly during the first UK lockdown. Revenue GP3.1 million, down from GBP3.3 million year before and swings to GBP478,000 pretax loss from GBP6,000 profit.

----------

Angle, down 9.7% at 79.30p, 12-month range 37.15p-98p. The liquid biopsy company says it has received response from US Food & Drug Administration after requesting clearance for its Parsortix treatment. Says FDA has indicated its review processes for non Covid-19 devices are currently slower than usual due to pandemic priorities. Notes that FDA processes are outside the company's control and it is continuing to expedite all aspects of the process which are under its control in line with previously advised timescales.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
4 Aug 2020 12:57

Futura Medical upbeat on cannabidiol gel lab work

(Sharecast News) - Pharmaceutical company Futura Medical announced the completion of initial laboratory and optimisation work on a 'Dermasys' cannabidiol gel, dubbed 'CBD100', under the joint venture collaboration agreement with CBDerma Technology that was announced in September.

Read more
14 Jul 2020 21:51

IN BRIEF: Futura Submits MED3000 Under EU Medical Device Regulation

IN BRIEF: Futura Submits MED3000 Under EU Medical Device Regulation

Read more
24 Jun 2020 11:45

Futura Medical Reports Limited Impact Of Covid-19 On Its Operations

Futura Medical Reports Limited Impact Of Covid-19 On Its Operations

Read more
24 Jun 2020 11:06

Futura makes good progress with topical erectile dysfunction treatment

(Sharecast News) - Futura Medical updated the market on Wednesday, reporting that the impact of the Covid-19 pandemic on the company had been "limited" to date.

Read more
18 Jun 2020 16:06

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
19 May 2020 09:45

UK BROKER RATINGS SUMMARY: JPMorgan Raises Homeserve To Overweight

UK BROKER RATINGS SUMMARY: JPMorgan Raises Homeserve To Overweight

Read more
20 Apr 2020 16:09

Futura files for second FDA meeting over erection gel

(Sharecast News) - Futura Medical has filed for a further pre-submission meeting with the US Food and Drug Administration (FDA), it announced on Monday, following receipt of the complete and signed clinical study report for its phase 3 Study, 'FM57'.

Read more
20 Apr 2020 13:24

Futura Files For Erectile Dysfunction Treatment Pre-Submission Meeting

Futura Files For Erectile Dysfunction Treatment Pre-Submission Meeting

Read more
1 Apr 2020 11:10

Futura Optimistic Over Approvals For Erectile Dysfunction Treatment

Futura Optimistic Over Approvals For Erectile Dysfunction Treatment

Read more
25 Mar 2020 16:08

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
13 Feb 2020 18:33

Futura Pursues Regulatory Approval For Erectile Dysfunction Treatment

Futura Pursues Regulatory Approval For Erectile Dysfunction Treatment

Read more
10 Jan 2020 16:10

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
23 Dec 2019 09:53

Futura Medical Raises GBP3.3 Million In Offer Backed By Lombard Odier

Futura Medical Raises GBP3.3 Million In Offer Backed By Lombard Odier

Read more
20 Dec 2019 16:53

Futura Medical To Raise GBP3.3 Million In Shares After Test Failure

Futura Medical To Raise GBP3.3 Million In Shares After Test Failure

Read more
10 Dec 2019 13:54

Futura Medical Erectile Dysfuction Drug MED2005 Fails To Beat Placebo

Futura Medical Erectile Dysfuction Drug MED2005 Fails To Beat Placebo

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.